Table 5. Side effects during the first year after anti-reflux surgery.
| Side effect | LINX (N=17) | FUNDO (N=17) |
|---|---|---|
| Overall | ||
| At least one side effect | 12 (70.6%) | 8 (47.1%) |
| Individual events | ||
| Dysphagia | 11 (64.7%) | 1 (5.9%) |
| Nausea or vomiting | 5 (29.4%) | 0 (0%) |
| Reflux symptoms | 3 (17.6%) | 3 (17.6%) |
| Throat pain | 2 (11.8%) | 0 (0%) |
| Belching | 1 (5.9%) | 0 (0%) |
| Esophageal spasm | 2 (11.8%) | 0 (0%) |
| Inability to belch | 0 (0%) | 1 (5.9%) |
| Inability to vomit | 0 (0%) | 3 (17.6%) |
| Bloating | 0 (0%) | 1 (5.9%) |
| Abdominal pain or cramping | 2 (11.8%) | 1 (5.9%) |
| Shortness of breath | 1 (5.9%) | 0 (0%) |
| Weight fluctuationsa | ||
| Body mass index (kg/m2) | ||
| Before anti-reflux surgery | 27.5 [23.9, 30.7] | 26.1 [23.6, 27.0] |
| 6 months after anti-reflux surgery | 27.6 [23.7, 30.7] | 26.6 [24.1, 28.4] |
| Weight change (kg)b | +2.0 [−1.1, +3.4] | −2.7 [−3.9, +2.3] |
a, continuous variables presented as median (interquartile range); b, before versus 6 months after anti-reflux surgery. LINX, LINX Reflux Management System; FUNDO, fundoplication.